The FEAST Research Study

Enhanced Spatial Targeting in ECT utilizing Focally Electrically-administered Seizure Therapy (FEAST)

If you…

  • Are 22-90 years old
  • Have severe depression & ECT has been suggested for you by your doctor
  • Do not have psychosis
  • Are not currently dependent on street drugs or alcohol

You may qualify for a research study of a form of ECT that may deliver treatments with minimal memory loss. Treatment includes the use of a focal electronically administered therapy (ECT) which has been shown to be an effective treatment of severe depression.

Disclaimer: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this website, is for general information purposes only. Please contact your physician to form a plan that addresses your specific needs.


    Study participation:

    • Up to 8 weeks including 4-5 weeks of treatment.
    • Involves no sham or placebo treatments.


    To learn more about the FEAST study, please contact the Interventional Psychiatry Lab study team, overseen by Dr. Ziad Nahas, Department of Psychiatry and Behavioral Studies, University of Minnesota. 952-525-4505 OR [email protected]